Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/b7/aa/13/b7aa1359-be55-54cb-aac4-5c940db0bb82/mza_9473527047321604804.jpg/600x600bb.jpg
Moving Medicine Forward
CTI Clinical Trials
34 episodes
1 day ago
CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.
Show more...
Life Sciences
Science
RSS
All content for Moving Medicine Forward is the property of CTI Clinical Trials and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.
Show more...
Life Sciences
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/39400744/39400744-1753897099545-e787b29af871f.jpg
Pitt Hopkins Research Foundation: A Mother's Story of Hope
Moving Medicine Forward
20 minutes 37 seconds
3 months ago
Pitt Hopkins Research Foundation: A Mother's Story of Hope

In this episode of “Moving Medicine Forward,” Audrey Davidow shares how her son’s diagnosis led to her co-founding the Pitt Hopkins Research Foundation. She explains the rare genetic disorder, the foundation’s focus on research and family support, and major breakthroughs such as a gene therapy trial. Audrey also reflects on advocacy, leadership challenges, and the hope driving their mission forward. 


Support the Pitt Hopkins Research Foundation by visiting PittHopkins.org or donating to the CTI Employee Fund.

01:09 Audrey Davidow shares how her son’s diagnosis led her to co-found the Pitt Hopkins Research Foundation. 

02:45 She explains Pitt Hopkins Syndrome as a rare genetic disorder caused by TCF4 gene mutations. 

04:35 Audrey recalls the early days of the foundation, driven by grief and an urgent need to act. 

06:01 The foundation remains focused on research while still offering family support. 

07:54 She highlights major breakthroughs, including a gene therapy trial. 

09:41 Funding is directed only to research with a clear path to patient impact. 

11:00 Support includes clinics, online communities, and global family conferences. 

12:22 Advocacy efforts aim to boost diagnosis rates and raise awareness among medical professionals.  

13:12 Challenges include translating science into treatments and navigating leadership without a science background. 

14:18 Audrey stays motivated by her son’s resilience and the progress made. 

15:31 How grassroots fundraisers have been highly successful. 

16:54 Top priorities include launching the gene therapy trial and advancing other genetic treatments. 

17:16 She encourages donations and everyday acts of inclusion for those with disabilities. 

18:50 Audrey offers a message of hope, emphasizing that meaningful progress is underway. 

Moving Medicine Forward
CTI Clinical Trial and Consulting Services presents Moving Medicine Forward, a podcast centered on advancements in healthcare and elevating individual’s stories and expertise. CTI, a global Contract Research organization with associates in 60 countries, has contributed to 10,000+ projects, 200+ drug and device approvals, and 300+ pharmaceutical and emerging biotechnology partners. Our group of innovative thinkers work to change the lives of chronically and critically ill patients.